Chemours Company (CC)’s Pretax Margin and Net Margin Explained

Chemours Company [CC] stock is trading at $27.30, down -0.76%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CC shares have gain 0.04% over the last week, with a monthly amount glided 4.60%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

On 9, April 2024, Chemours Recognized for Sustainability Achievements at the U.S. Department of Energy Better Buildings, Better Plants Summit. In a post published today on Yahoo Finance, The Chemours Company

From an analyst’s perspective:

Chemours Company [NYSE: CC] stock has seen the most recent analyst activity on April 09, 2024, when BMO Capital Markets upgraded its rating to a Outperform and also boosted its price target to $34 from $19. Previously, UBS downgraded its rating to Neutral on March 05, 2024, and dropped its price target to $21. On February 29, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $19 on the stock. RBC Capital Mkts upgraded its rating to a Outperform and increased its price target to $40 on December 01, 2023. BofA Securities downgraded its rating to a Neutral and reduced its price target to $37 on June 22, 2023. UBS upgraded its rating to Buy for this stock on January 24, 2023, and upped its price target to $43. In a note dated January 11, 2023, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $37 to $40.

Chemours Company [CC] stock has fluctuated between $15.10 and $39.05 over the past year. Currently, Wall Street analysts expect the stock to reach $32.38 within the next 12 months. Chemours Company [NYSE: CC] shares were valued at $27.30 at the most recent close of the market. An investor can expect a potential return of 18.61% based on the average CC price forecast.

Analyzing the CC fundamentals

Chemours Company [NYSE:CC] reported sales of 6.03B for the trailing twelve months, which represents a growth of 1.72%. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.27 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of5.49.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.00 points at the first support level, and at 26.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.63, and for the 2nd resistance point, it is at 27.97.

Chemours Company [CC] reported earnings per share of $0.31 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.25/share, meaning a difference of $0.06 and a surprise factor of 24.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.63 per share as compared to estimates of $0.69 per share, a difference of -$0.06 representing a surprise of -8.70%.

Ratios To Look Out For

For context, Chemours Company’s Current Ratio is 1.54. In addition, the Quick Ratio stands at 1.00 and the Cash Ratio stands at 0.73. Considering the valuation of this stock, the price to sales ratio is 0.67, the price to book ratio is 5.50.

Transactions by insiders

Recent insider trading involved Newman Mark, President and CEO, that happened on Jun 09 ’23 when 7661.0 shares were purchased. SVP Corp Communications & CBO, Scarborough Alvenia completed a deal on Jun 09 ’23 to sell 5125.0 shares. Meanwhile, SVP, Chief Enterprise Transfor Abbott Matthew S sold 8912.0 shares on Jun 08 ’23.

Related Posts